Allen & Hanburys Ltd

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 17/01/2012
PIL Serevent Evohaler

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 24/08/2011 and displayed until 17/01/2012
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 15/07/2010 and displayed until 24/08/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 06/01/2010 and displayed until 15/07/2010
Reasons for adding or updating:
  • Change to instructions about overdose
Updated on 30/03/2009 and displayed until 06/01/2010
Reasons for adding or updating:
  • Change to drug interactions
Updated on 08/08/2007 and displayed until 30/03/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Change due to harmonisation of patient information leaflet
  • Change due to user-testing of patient information
Updated on 04/01/2006 and displayed until 08/08/2007
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   salmeterol xinafoate